Jaguar Health's Study Shows Mytesi (Crofelemer) May Support Treatment of Diarrhea in Cancer Patients Receiving Targeted Therapy While Also Enabling Maintenance and Tolerability of a Higher Dose of the Selected TKI
Stock Information for Jaguar Health Inc.
Loading
Please wait while we load your information from QuoteMedia.